OMOP 2009 Symposium Presentations

Keynote: Setting the Stage: Challenges of Observational Data
Clement J. McDonald, MD
Director of the Lister Hill National Center for Biomedical Communications at the National Library of Medicine; Member of OMOP Healthcare Informatics Advisory Board

OMOP Progress and Key Research Questions
Marc Overhage, MD, PhD
Director, Medical Informatics and Research Scientist, Regenstrief Institute, Inc.
Regenstrief Professor of Medical Informatics, Indiana University School of Medicine; CEO and President Indiana Health Information Exchange; OMOP Principal Investigator

OMOP Progress and Key Research Questions from Foundation for NIH on Vimeo.

Summary of OMOP Data Provider Survey
Abraham G. Hartzema PharmD, MSPH, PhD, FISPE
Professor and Eminent Scholar, Perry A. Foote Chair in Health Outcomes and Pharmacoeconomics; Professor, Department of Epidemiology and Biostatistics, College of Public Health and Health Professions, University of Florida; OMOP Principal Investigator

Technical Requirements for Active Surveillance
Christian Reich, MD, PhD (FNIH), Alex Cheminshy (CSC), and Shaun Grannis, MD, MS, AAFP (Regenstrief Institute)

Technical Requirements for Active Surveillance from Foundation for NIH on Vimeo.

OMOP Common Data Model and Vocabulary
Marc Overhage (OMOP Principal Investigator), Shawn Murphy, MD, PhD (Partners Healthcare System), Greg Hess, MD, MBA, MSc (SDI), and Arnold Chan, MD, ScD, FISPE (i3 Drug Safety)

Health Outcomes of Interest - Create the Definition
Paul Stang, PhD (OMOP Principal Investigator), Judith A. Racoosin, MD, MPH (FDA), and Vinit Nair BPharm, MS, RPh and Qianli Ma (Humana)

Methods Development & Evaluation
Patrick Ryan, MEng (OMOP Principal Co-Investigator), Stephanie Reisinger (ProSanos Corporation) and David Madigan, PhD (Columbia University)

OMOP Methods Development and Evaluation from Foundation for NIH on Vimeo.

International Perspectives – Drug Safety Initiatives
The Netherlands: Prof. Dr. Miriam CJM Sturkenboom, EU-ADR, Department Medical Informatics, Erasmus University Medical Center
Japan: Ayumi Endo, Professional Staff, Surveillance and Analysis Division Pharmaceuticals and Medical Devices Agency, PMDA, Japan
United Kingdom: John Parkinson, BSc, PhD, Director, GPRD & Expert Advisor to the Research Capability Programme

Establishing an OMOP Extended Consortium
Amy Porter, Executive Director, Foundation for the National Institutes of Health